TELA Bio Inc. (TELA) Announces Proposed 3M Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
TELA Bio Announces Proposed Public Offering of Common Stock
June 23, 2020 4:16 PM EDTMALVERN, Pa., June 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced the commencement of a proposed underwritten public offering of 3,000,000 shares of its common stock. Â In addition, TELA expects to grant the underwriters a 30-day option to purchase up to 450,000 additional shares of common stock in the offering. Â All shares of common stock are being offered by TELA. Â The offering is subject to market and other conditions, and there can be... More
